Skip to main content
SpringerLink
Log in

Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strain

  • Viruses
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

An abnormal immune response towards the Epstein-Barr virus (EBV) has been documented in patients with rheumatoid arthritis (RA). To investigate whether these findings are due to the transformation event caused by EBV, RA blood mononuclear cells and monocyte-enriched preparations were incubated with two different EBV strains: the transforming virus secreted by the cell line B95-8 and the virus released by the P3HR-1 cell line that is not able to transform due to a small deletion in the U2 region of the virus genome. Immunological response was determined by the production of interleukin-1 (IL-1) and tumor necrosis factor (TNF) using ELISA and bioassay systems. There was a striking difference in cytokine measurements with a strong inhibition of IL-1 and TNF production after incubation with the B95-8 virus, but not the P3HR-1 virus. These data indicate that the disturbed reaction of the immune system towards EBV is either dependent on the full transformation of B cells in RA patients or alternatively due to the secretion of a cytokine inhibitor by the B95-8 cell line.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Venables PJW (1988) Leading article: Epstein-Barr virus infection and autoimmunity in rheumatoid arthritis. Ann Rheum Dis 47:265–269

    Google Scholar 

  2. Tosato G, Steinberg AD, Blaese RM (1981) Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med 305:1238–1243

    Google Scholar 

  3. Fawcett M-C, Walker DJ, Griffiths ID (1988) Demonstration of impaired T cell regulation of Epstein-Barr virus stimulated B lymphocytes in rheumatoid arthritis with HLA identical, disease discordant sibling pairs. Ann Rheum Dis 47:372–376

    Google Scholar 

  4. Slaughter L, Carson DA, Jensen FC, Holbrook TL, Vaughan JH (1978) In-vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects. J Exp Med 148:1429–1434

    Google Scholar 

  5. Gordon J, Guy G, Walker L (1987) A model for the first activation cycle of human B lymphocytes. In: Ferrarini M, Pernis B (eds) The molecular basis of B-cell differentiation and function. NATO ASI Series, pp 79–82

  6. Hurley EA, Thorley-Lawson DA (1988) B cell activation and the establishment of Epstein-Barr virus latency. J Exp Med 168:2059–2075

    Google Scholar 

  7. Thorley-Lawson DA (1980) The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell. J Immunol 124:745–751

    Google Scholar 

  8. Svedmyr R, Jondal M (1975) Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci 72:1622–1628

    Google Scholar 

  9. Lotz M, Tsoukas CD, Fong S, Dinarello CA, Carson DA, Vaughan JH (1986) Release of lymphokines after Epstein-Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans. J Immunol 136:3636–3642

    Google Scholar 

  10. Lotz M, Tsoukas CD, Curd JG, Carson DA, Vaughan JH (1987) Effects of recombinant human interferons on rheumatoid arthritis B lymphocytes activated by Epstein-Barr virus. J Rheumatol 14:42–45

    Google Scholar 

  11. Lotz M, Tsoukas CD, Fong S, Carson DA, Vaughan JH (1985) Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon gamma. Eur J Immunol 15:520–525

    Google Scholar 

  12. Lotz M, Tsoukas CD, Fong S, Dinarello CA, Carson DA, Vaughan JH (1986) Release of lymphokines after Epstein-Barr virus infection in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon gamma in rheumatoid arthritis. J Immunol 136:3643–3648

    Google Scholar 

  13. Lotz M, Roudier J (1989) Epstein-Barr virus and rheumatoid arthritis: cellular and molecular aspects. Rheumatol Int 9

  14. Bornkamm GW, Delius H, Zimber U, Hudewentz J, Epstein MA (1980) Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. J Virol 35:603–618

    Google Scholar 

  15. Hennessy K, Kieff E (1985) A second nuclear protein is encoded by Epstein-Barr virus in latent infection. Science 227:1238–1240

    Google Scholar 

  16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Google Scholar 

  17. Thorley-Lawson DA, Chess L, Strominger JL (1977) Suppression of in vitro Epstein-Barr virus infection: a new role for adult human T lymphocytes. J Exp Med 146:495–508

    Google Scholar 

  18. Kupper T, Horowitz M, Lee F, Robb R, Flood PM (1987) Autocrine growth of T cells independent of interleukin 2; identification of interleukin 4 (IL 4, BSF-1) as an autocrine growth factor for a cloned antigen-specific helper T cell. J Immunol 138:4280–4287

    Google Scholar 

  19. Linker-Israeli M, Bakke AC, Quismorio FP, Horwitz DA (1985) Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J Clin Invest 75:762–770

    Google Scholar 

  20. Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YCE, Mathison J, Ulevitch R, Cerami A (1985) Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature 316:552–555

    Google Scholar 

  21. Hasler F, Bluestein HG, Zvaifler NJ, Epstein LB (1983) Analysis of the defects responsible for the impaired regulation of EBV induced B cell proliferation by rheumatoid arthritis lymphocytes: II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E. J. Immunol 131:768–772

    Google Scholar 

  22. Gaston JSH, Rickinson AB, Yao QY, Epstein MA (1986) The abnormal cytotoxic T cell response to Epstein-Barr virus in rheumatoid arthritis is correlated with disease activity and occurs in other arthropathies. Ann Rheum Dis 45:932–936

    Google Scholar 

  23. Gramatzki M, Baum W, Kirchhoff H, Leibold W, Kirchner H, Doldi K, Kalden JR (1985) An inhibitor of interleukin 2 response produced by mycoplasma infected cell lines. Immunobiology 170:24–25 (abstr)

    Google Scholar 

  24. Baum W, Koch B, Burmester GR, Giedl J, Reinke M, Zacher J, Kalden JR (1988) Prostaglandin E2 and interleukin 1ß production in mononuclear cells of patients with rheumatoid arthritis and Crohns disease. Immunobiology 178:88–89

    Google Scholar 

  25. Dayer JM, Beutler B, Cerami A (1985) Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163–2172

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Clinical Immunology, Department of Medicine III, Erlangen Medical School, University of Erlangen-Nürnberg, Krankenhausstrasse 12, D-8520, Erlangen, Germany

    T. Häupl, G. R. Burmester, G. Hahn & J. R. Kalden

  2. Research Laboratories, Pharmaceutical Division, Ciba-Geigy Ltd., CH-4002, Basel, Switzerland

    U. Feige & C. Rordorf-Adam

Authors
  1. T. Häupl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. R. Burmester
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Hahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Feige
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Rordorf-Adam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. R. Kalden
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Häupl, T., Burmester, G.R., Hahn, G. et al. Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strain. Rheumatol Int 9, 153–160 (1989). https://doi.org/10.1007/BF00271873

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00271873

Key words

Search

Navigation